Introduction to PD-1 Clinical Trials
Medical Supporter — Information Notice
This article is a summary of international medical information and is not medical advice; it cannot replace the diagnosis or treatment plan of your attending physician. The medical technologies, drug information and clinical data presented here are compiled from public literature and official statements of major Japanese medical institutions; the applicability and outcome of any therapy vary with each patient and must be assessed individually by a qualified physician.
Today is Christmas, and as children we always looked forward to what presents might arrive. We hope that all our followers are doing well. This time, we would like to introduce a clinical trial for Nivolumab targeting patients with non-small cell lung cancer. Please refer to the link below for more detailed information. This is a Phase 2 clinical trial, and the principal investigator is Dr. Nakagawa at Kinki University.
Since overseas medical treatment costs are not inexpensive, Medical Supporter is here to help navigate the process. We assist patients in understanding their options, coordinating with hospitals, and reducing the burden of seeking treatment abroad.
Medical Supporter was formerly certified as an international medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).
Considering medical care in Japan? Need information and support?
We help you organize the information needed for medical travel to Japan, liaise with Japanese medical institutions, and arrange a second-opinion consultation.The first consultation is free; an advisor will help you clarify the next steps.
Figure 1
Figure 2
Figure 3
Figure 4